#
Dextroamphetamine Transdermal
  • Drugs A to Z
  • Dextroamphetamine (Transdermal)

Dextroamphetamine (Transdermal)

Medically reviewed by Drugs.com. Last updated on Apr 15, 2022.

Transdermal route(Patch, Extended Release)

CNS stimulants, including dextroamphetamine, other amphetamine-containing products, and methylphenidate, have high potential for abuse and dependence. Assess the risk of abuse prior to prescribing and monitor for signs of abuse and dependence while on therapy .

Commonly used brand name(s)

In the U.S.

  • Xelstrym

Chemical Class: Amphetamine (class)

Uses for dextroamphetamine

Dextroamphetamine transdermal patch is used to treat attention-deficit hyperactivity disorder (ADHD). It belongs to the group of medicines called central nervous system (CNS) stimulants.

Dextroamphetamine works in the treatment of ADHD by increasing attention and decreasing restlessness in children and adults who are overactive, cannot concentrate for very long, or are easily distracted and impulsive. Dextroamphetamine is used as part of a total treatment program that also includes social, educational, and psychological treatment.

Dextroamphetamine is available only with a doctor's prescription.

Before using dextroamphetamine

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For dextroamphetamine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to dextroamphetamine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of dextroamphetamine transdermal patch in children younger than 6 years of age. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of dextroamphetamine transdermal patch in the elderly. However, elderly patients are more likely to ha..